v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows – operating activities:    
Net loss $ (643) $ (1,794)
Non-cash items –     
Share-based plans expense 254 208
Treasury shares issued for 401(k) contribution 793 953
Depreciation and amortization 926 883
Investment/asset impairment charges, net 30 34
Gain on dispositions, net (64) (5)
Other charges and credits, net 162 (34)
Changes in assets and liabilities –     
Accounts receivable (683) (522)
Unbilled receivables (908) (1,345)
Advances and progress billings (616) 1,886
Inventories (374) (5,937)
Other current assets 265 (320)
Accounts payable (46) (222)
Accrued liabilities (248) (443)
Income taxes receivable, payable and deferred (3) (188)
Other long-term liabilities (212) (148)
Pension and other postretirement plans (292) (491)
Financing receivables and operating lease equipment, net 185 149
Other 85 51
Net cash used by operating activities (1,389) (7,285)
Cash flows – investing activities:    
Payments to acquire property, plant and equipment (1,101) (971)
Proceeds from disposals of property, plant and equipment 4 30
Acquisitions, net of cash acquired (50)
Proceeds from dispositions 35
Contributions to investments (21,581) (1,617)
Proceeds from investments 18,847 3,173
Supplier notes receivable (150) (486)
Purchase of distribution rights (88)
Other (17)
Net cash used by investing activities (3,946) (26)
Cash flows – financing activities:    
New borrowings 98 10,089
Debt repayments (677) (4,481)
Employee taxes on certain share-based payment arrangements (18) (67)
Dividends paid on mandatory convertible preferred stock (158)
Other 30 (3)
Net cash (used)/provided by financing activities (725) 5,538
Effect of exchange rate changes on cash and cash equivalents 34 (25)
Net decrease in cash & cash equivalents, including restricted (6,026) (1,798)
Cash & cash equivalents, including restricted, at beginning of year 13,822 12,713
Cash & cash equivalents, including restricted, at end of period 7,796 10,915
Less restricted cash & cash equivalents, included in Investments 709 21
Cash and cash equivalents at end of period $ 7,087 $ 10,894